This was discovered by Wang et al., who found that ICOSL KO mice had lower levels of Th17-associated cytokines (IL-17/IL-21), IL-13, and TGF-β1, which is correlated with improved survival rate, alleviated liver granulomatous inflammation, and hepatic fibrosis development (68). The gene discussed is IL17A; the disease is Hepatic fibrosis.